Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127603501 | 12760350 | 1 | I | 20160913 | 20160919 | 20160919 | EXP | US-PFIZER INC-2016433849 | PFIZER | 52.00 | YR | M | Y | 111.13000 | KG | 20160919 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127603501 | 12760350 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 1X/DAY (ONCE AT NIGHT TIME) | N67728 | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | |||||
127603501 | 12760350 | 2 | C | TRIAZOLAM. | TRIAZOLAM | 1 | Oral | 0.25 MG, 3X/DAY THREE TIMES AT NIGHT | 0 | .25 | MG | TABLET | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127603501 | 12760350 | 1 | Depression |
127603501 | 12760350 | 2 | Insomnia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127603501 | 12760350 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127603501 | 12760350 | Dysuria | |
127603501 | 12760350 | Urinary retention | |
127603501 | 12760350 | Urine output decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127603501 | 12760350 | 1 | 20160721 | 0 | ||
127603501 | 12760350 | 2 | 1986 | 0 |